Crossref journal-article
Wiley
Immunological Reviews (311)
Abstract

Summary:The Wiskott–Aldrich syndrome protein (WASp) has emerged as a central player in the regulation of actin remodeling in T cells. The unique domain structure of WASp and other WASp family members enables these proteins to associate with a myriad of signaling effectors and to thereby regulate the coupling of T cell antigen receptor (TCR) engagement to both cytoskeletal rearrangement and transcriptional activation. This review focuses on these biochemical properties of WASp and also on the mechanisms whereby WASp interactions with its cognate ligands influence T cell activation. Because of its capacity to shift intracellular location and thereby dictate both the timing and the spatial distribution of actin polymerization following cell stimulation, WASp is well positioned to play major regulatory roles in directing a wide range of cellular processes and signaling pathways. Further dissection of the functional and biochemical properties of WASp therefore represents a promising avenue towards defining the molecular mechanisms that convey TCR stimulatory signals to the actin cytoskeleton and integrate cytoskeletal and other signaling systems so as to evoke a biological response.

Bibliography

Badour, K., Zhang, J., & Siminovitch, K. A. (2003). The Wiskott–Aldrich syndrome protein: forging the link between actin and cell activation. Immunological Reviews, 192(1), 98–112. Portico.

Authors 3
  1. Karen Badour (first)
  2. Jinyi Zhang (additional)
  3. Katherine A. Siminovitch (additional)
References 147 Referenced 68
  1. 10.1002/1097-0169(200006)46:2<73::AID-CM1>3.0.CO;2-0
  2. 10.1038/376307a0
  3. 10.1074/jbc.274.46.32529
  4. 10.1038/25764
  5. 10.1073/pnas.95.11.6302
  6. 10.1126/science.282.5397.2266
  7. 10.1016/0092-8674(94)90528-2
  8. 10.1016/0002-9343(68)90051-X
  9. 10.1182/blood.V87.7.2621.bloodjournal8772621
  10. 10.1182/blood.V90.8.3089 / Blood / Defective actin reorganization and poly‐merizationof Wiskott–Aldrich T cells in response to CD3‐mediated stimulation by Galego MD (1997)
  11. 10.1046/j.1365-2141.1997.1132938.x
  12. {'key': 'e_1_2_6_13_2', 'first-page': '80', 'article-title': 'Wiskott–Aldrich syndrome: new perspectives in pathogenesis and management', 'volume': '22', 'author': 'Standen GR.', 'year': '1988', 'journal-title': 'J R Coll Physicians London'} / J R Coll Physicians London / Wiskott–Aldrich syndrome: new perspectives in pathogenesis and management by Standen GR. (1988)
  13. 10.1016/S0022-3476(05)82002-5
  14. 10.1007/s004390050162
  15. 10.1007/s004390050285
  16. 10.1046/j.1365-2141.2001.02832.x
  17. 10.1172/JCI118712
  18. 10.1002/j.1460-2075.1996.tb00917.x
  19. 10.1083/jcb.142.5.1325
  20. 10.1093/emboj/17.23.6932
  21. 10.1006/bbrc.1999.0894
  22. 10.1083/jcb.152.1.1
  23. 10.1083/jcb.136.3.649
  24. 10.1016/S0092-8674(00)81341-0
  25. 10.1074/jbc.274.33.23549
  26. 10.1038/386284a0
  27. 10.1016/S0014-5793(02)02751-5
  28. 10.1093/emboj/16.17.5433
  29. 10.1038/10717
  30. 10.1038/372375a0
  31. 10.1016/S0092-8674(02)01076-0
  32. 10.1073/pnas.94.26.14671
  33. 10.1038/35074551
  34. 10.4049/jimmunol.164.6.2866
  35. 10.1006/bbrc.2002.6406
  36. 10.1073/pnas.211420498
  37. 10.1016/S0960-9822(02)00423-2
  38. 10.1074/jbc.270.49.29071
  39. 10.1126/science.279.5350.509
  40. 10.1016/S0092-8674(00)81050-8
  41. 10.1074/jbc.274.38.27225
  42. 10.1016/S0092-8674(00)80732-1
  43. 10.1126/science.290.5492.801
  44. 10.1038/35004513
  45. 10.1038/85886
  46. 10.1016/S1074-7613(01)00178-9
  47. 10.1074/jbc.273.29.18067
  48. 10.1083/jcb.150.6.1299
  49. 10.1083/jcb.150.6.1311
  50. 10.1128/MCB.15.10.5725
  51. 10.1016/S0960-9822(02)00642-5
  52. {'key': 'e_1_2_6_53_2', 'first-page': '195', 'article-title': 'Tyrosine kinase signaling regulates Wiskott–Aldrich syndrome protein function, which is essential for megakaryocyte differentiation', 'volume': '8', 'author': 'Miki H', 'year': '1997', 'journal-title': 'Cell Growth Differ'} / Cell Growth Differ / Tyrosine kinase signaling regulates Wiskott–Aldrich syndrome protein function, which is essential for megakaryocyte differentiation by Miki H (1997)
  53. 10.1182/blood.V93.6.2003.406k13_2003_2012
  54. 10.1074/jbc.275.11.7854
  55. 10.1182/blood.V97.9.2633
  56. 10.1084/jem.194.12.1777
  57. BadourK et al.The Wiskott–Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse.Immunity2003;18:141154. (10.1016/S1074-7613(02)00516-2)
  58. 10.4049/jimmunol.157.9.3791 / J Immunol / Evidence that the Wiskott–Aldrich syndrome protein may be involved in lymphoid cell signaling pathways by Cory GO (1996)
  59. 10.1091/mbc.8.9.1709
  60. 10.1242/jcs.115.4.699 / J Cell Sci / N‐WASp activation by a β1‐integrin‐dependent mechanism supports P13K‐independent chemotaxis stimulated by urokinase‐type plasminogen activator by Sturge J (2002)
  61. 10.1074/jbc.M103856200
  62. 10.1074/jbc.M000687200
  63. 10.1083/jcb.152.3.471
  64. 10.1093/emboj/17.22.6516
  65. 10.1083/jcb.150.5.1001
  66. 10.1074/jbc.M003882200
  67. {'key': 'e_1_2_6_68_2', 'first-page': '226291', 'article-title': 'domains', 'volume': '271', 'author': 'Finan PM', 'year': '1996', 'journal-title': 'J Biol Chem'} / J Biol Chem / domains by Finan PM (1996)
  68. 10.1074/jbc.M202783200
  69. 10.1084/jem.190.9.1329
  70. 10.1016/S1074-7613(00)80115-6
  71. 10.1038/35047107
  72. 10.1093/emboj/20.20.5603
  73. 10.1016/S0960-9822(98)00015-3
  74. 10.1016/S0014-5793(01)03242-2
  75. 10.1073/pnas.95.11.6181
  76. 10.1038/35050590
  77. 10.1074/jbc.M106520200
  78. 10.1073/pnas.96.7.3739
  79. 10.1016/S0960-9822(99)80243-7
  80. 10.1021/bi991843
  81. 10.1074/jbc.C100476200
  82. 10.1016/S0960-9822(00)00749-1
  83. 10.1038/20726
  84. 10.1074/jbc.M203346200
  85. 10.1074/jbc.M106428200
  86. 10.1182/blood.V55.2.243.243 / Blood / The Wiskott–Aldrich syndrome: studies of lymphocytes, granulocytes and platelets by Ochs HD (1980)
  87. 10.4049/jimmunol.104.4.835 / J Immunol / Defective lymphocyte transformation and delayed hypersensitivity in Wiskott–Aldrich syndrome by Oppenheim JJ (1970)
  88. 10.4049/jimmunol.151.8.4383 / J Immunol / T cells of patients with the Wiskott–Aldrich syndrome have a restricted defect in proliferative response by Molina IJ (1993)
  89. {'key': 'e_1_2_6_90_2', 'first-page': '159', 'article-title': 'A diagnostic assay for the Wiskott–Aldrich syndrome and its variant forms', 'volume': '43', 'author': 'Siminovitch KA', 'year': '1995', 'journal-title': 'J Invest Med'} / J Invest Med / A diagnostic assay for the Wiskott–Aldrich syndrome and its variant forms by Siminovitch KA (1995)
  90. 10.1016/S1074-7613(00)80590-7
  91. 10.1007/PL00008395
  92. 10.1073/pnas.042686099
  93. 10.1139/o89-081
  94. 10.1016/S1074-7613(00)80054-0
  95. 10.1016/S0092-8674(00)81368-9
  96. 10.1074/jbc.273.33.20992
  97. 10.1083/jcb.149.1.181
  98. 10.1242/jcs.114.23.4307 / J Cell Sci / Evidence for a molecular complex consisting of Fyb/SLAP, SLP‐76, Nck, VASP and WASp that links the actin cytoskeleton to Fcγ receptor signaling during phagocytosis by Coppolino MG (2001)
  99. 10.4049/jimmunol.128.3.1159 / J Immunol / The area of attachment of cytotoxic T lymphocytes to their target cells shows high motility and polarization of actin, but not myosin by Ryser JE (1982)
  100. 10.1084/jem.181.2.577
  101. 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E
  102. 10.1126/science.285.5425.221
  103. 10.1126/science.1067710
  104. 10.1084/jem.179.5.1507
  105. 10.1016/0092-8674(94)90332-8
  106. 10.1083/jcb.138.4.845
  107. 10.1093/emboj/17.24.7320
  108. 10.1016/S0092-8674(00)81608-6
  109. 10.1074/jbc.272.49.30889
  110. 10.1016/S0960-9822(95)00019-4
  111. 10.1093/emboj/18.3.501
  112. 10.1084/jem.165.6.1565
  113. 10.1073/pnas.92.11.5027
  114. 10.1083/jcb.142.2.457
  115. 10.1091/mbc.01-12-0579
  116. 10.1074/jbc.M110172200
  117. 10.1084/jem.165.4.1141
  118. 10.1002/eji.1830170715
  119. 10.1002/eji.1830260907
  120. 10.1126/science.286.5441.952
  121. 10.1093/emboj/18.5.1159
  122. 10.1074/jbc.274.22.15671
  123. 10.1016/S0014-5793(00)01793-2
  124. 10.1007/BF01952099
  125. 10.1093/emboj/cdf604
  126. 10.1074/jbc.273.2.685
  127. 10.1016/S0021-9258(19)61526-7
  128. 10.1182/blood.V95.9.2943.009k17_2943_2946
  129. 10.4049/jimmunol.161.2.1026 / J Immunol / Monocytes from Wiskott–Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein‐1 and formyl‐methionyl‐leucyl‐phenylalanine by Badolato R (1998)
  130. 10.1046/j.1365-2141.1998.00767.x
  131. 10.4049/jimmunol.165.1.221
  132. 10.1182/blood.V98.4.1142
  133. 10.1002/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B
  134. 10.1002/1521-4141(200112)31:12<3413::AID-IMMU3413>3.0.CO;2-P
  135. 10.1182/blood.V98.4.1086
  136. 10.1182/blood.V97.1.33
  137. 10.1016/S0896-6273(00)81092-2
  138. 10.1242/jcs.114.8.1555
  139. 10.1016/S0960-9822(02)01035-7
  140. 10.1126/science.1072309
  141. 10.1074/jbc.M010729200
  142. 10.1126/science.274.5295.2086
  143. 10.1038/36362
  144. 10.1016/S0955-0674(00)00190-3
  145. 10.1016/S1074-7613(00)80577-4
  146. 10.1016/S0960-9822(00)00384-5
  147. 10.1016/S1074-7613(02)00360-6
Dates
Type When
Created 21 years, 7 months ago (Jan. 12, 2004, 6:43 a.m.)
Deposited 1 year, 10 months ago (Oct. 13, 2023, 4:06 p.m.)
Indexed 5 months ago (March 30, 2025, 1:04 a.m.)
Issued 22 years, 4 months ago (April 1, 2003)
Published 22 years, 4 months ago (April 1, 2003)
Published Online 22 years, 4 months ago (April 2, 2003)
Published Print 22 years, 4 months ago (April 1, 2003)
Funders 0

None

@article{Badour_2003, title={The Wiskott–Aldrich syndrome protein: forging the link between actin and cell activation}, volume={192}, ISSN={1600-065X}, url={http://dx.doi.org/10.1034/j.1600-065x.2003.00031.x}, DOI={10.1034/j.1600-065x.2003.00031.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Badour, Karen and Zhang, Jinyi and Siminovitch, Katherine A.}, year={2003}, month=apr, pages={98–112} }